pd 169316 has been researched along with Lung Neoplasms in 1 studies
2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Bittencourt Pasquali, MA | 1 |
| Gelain, DP | 1 |
| Zeidán-Chuliá, F | 1 |
| Pires, AS | 1 |
| Gasparotto, J | 1 |
| Terra, SR | 1 |
| Moreira, JC | 1 |
1 other study available for pd 169316 and Lung Neoplasms
| Article | Year |
|---|---|
Vitamin A (retinol) downregulates the receptor for advanced glycation endproducts (RAGE) by oxidant-dependent activation of p38 MAPK and NF-kB in human lung cancer A549 cells.
Topics: alpha-Tocopherol; Antioxidants; Cell Line, Tumor; Down-Regulation; Humans; Imidazoles; Lung Neoplasm | 2013 |